LGT Fund Management »

United Therapeutics Corporation shares owned by LGT Fund Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by LGT Fund Management from 13F filings

Historical chart of LGT Fund Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by LGT Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by LGT Fund Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $2.0M 6.7k 308.27
2024-12-31 $2.3M 6.7k 352.84

More positions owned by LGT Fund Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Visa Com Cl A (V)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
salesforce (CRM)
Coca-Cola Company (KO)
Eli Lilly & Co. (LLY)
Blackrock (BLK)
Broadcom (AVGO)
S&p Global (SPGI)

View all positions for LGT Fund Management

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Invesco
Assetmark
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation